VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 28 filers reported holding VERRICA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $18,497,000 | +10.6% | 1,479,733 | 0.0% | 0.20% | +20.1% |
| Q2 2021 | $16,721,000 | -25.4% | 1,479,733 | 0.0% | 0.17% | -19.5% |
| Q1 2021 | $22,418,000 | +31.6% | 1,479,733 | 0.0% | 0.21% | +40.9% |
| Q4 2020 | $17,032,000 | +48.7% | 1,479,733 | 0.0% | 0.15% | +3.5% |
| Q3 2020 | $11,453,000 | -29.7% | 1,479,733 | 0.0% | 0.14% | -37.1% |
| Q2 2020 | $16,292,000 | +0.7% | 1,479,733 | 0.0% | 0.23% | -15.8% |
| Q1 2020 | $16,173,000 | -31.2% | 1,479,733 | 0.0% | 0.27% | -19.0% |
| Q4 2019 | $23,513,000 | +7.7% | 1,479,733 | 0.0% | 0.34% | -18.8% |
| Q3 2019 | $21,841,000 | +27.0% | 1,479,733 | 0.0% | 0.41% | +55.6% |
| Q2 2019 | $17,194,000 | +7.5% | 1,479,733 | 0.0% | 0.27% | +7.3% |
| Q1 2019 | $15,996,000 | +32.6% | 1,479,733 | 0.0% | 0.25% | +11.2% |
| Q4 2018 | $12,060,000 | -49.8% | 1,479,733 | 0.0% | 0.22% | -23.1% |
| Q3 2018 | $24,046,000 | -17.6% | 1,479,733 | 0.0% | 0.29% | -16.7% |
| Q2 2018 | $29,195,000 | – | 1,479,733 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Altium Capital Management LP | 108,794 | $1,252,000 | 0.47% |
| Perceptive Advisors | 3,410,412 | $39,254,000 | 0.42% |
| KNOTT DAVID M | 76,585 | $881,000 | 0.40% |
| Fosun International Ltd | 324,061 | $3,730,000 | 0.24% |
| Orbimed Advisors | 1,479,733 | $17,032,000 | 0.15% |
| SteelPeak Wealth, LLC | 132,961 | $1,530,000 | 0.14% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 665,511 | $7,660,000 | 0.13% |
| Capital Investment Advisory Services, LLC | 15,125 | $174,000 | 0.03% |
| BECK MACK & OLIVER LLC | 10,000 | $115,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 335,318 | $3,860,000 | 0.00% |